Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Losing a tooth whole, with the root still attached and little to no bleeding, is a distinctive clinical sign of hypophosphatasia (HPP), and there are several important details to consider below. In HPP, low tissue-nonspecific alkaline phosphatase activity impairs cementum formation, so the periodontal ligament never anchors the tooth properly and it exfoliates intact instead of the root resorbing first, as happens in normal childhood tooth loss. This most often affects the front primary teeth (incisors) before age five and is frequently the earliest, and sometimes only, visible sign of milder HPP, which is why a persistently low serum alkaline phosphatase level and ALPL gene testing matter so much. Because premature tooth loss can also stem from trauma, severe gum disease, or other rare metabolic conditions, the full picture below explains what distinguishes HPP from these look-alikes and why timing, tooth type, and bone or growth symptoms all factor in.
If you or your child has lost a tooth root-and-all, or you are noticing bone pain, delayed walking, frequent fractures, or unexplained dental problems, a free, instant, online symptom check can help you organize what you are seeing, understand which conditions fit the pattern, and walk into your next appointment knowing which tests and specialists to ask about.
Last reviewed for medical accuracy: 08/18/2026
Early tooth loss without root resorption is a striking clinical clue that often leads clinicians to consider hypophosphatasia (HPP). In most conditions where teeth are lost prematurely—such as trauma, severe decay or periodontal disease—the roots show signs of resorption. When a tooth comes out intact, with its root structure preserved, it points in a very specific direction: a deficiency of tissue-nonspecific alkaline phosphatase (TNSALP), the hallmark of HPP.
HPP is a rare, inherited metabolic disorder characterized by defects in bone mineralization and by low levels of alkaline phosphatase (ALP) in blood and tissues.
• Genetics: Mutations in the ALPL gene lead to reduced activity of TNSALP.
• Enzyme dysfunction: TNSALP normally breaks down compounds like inorganic pyrophosphate (PPi), which—in excess—blocks bone and tooth mineralization.
• Spectrum of severity: HPP can present in utero, in infancy, childhood or adulthood. Severity ranges from life-threatening bone defects in newborns to mild adult-onset symptoms such as stress fractures and tooth loss.
In a healthy mouth, periodontal ligaments and cementum anchor the tooth root firmly to the jawbone. As baby teeth (deciduous teeth) are naturally replaced, root resorption occurs to allow exfoliation. In HPP:
Key dental features in HPP:
Because this pattern is so specific, “early tooth loss without root resorption” has become a pathognomonic sign for HPP in pediatric and adult patients alike.
While the dental clue can be the first hint, HPP often involves multiple systems:
Bone and Skeletal
Muscle and Neurological
Respiratory
Biochemical
HPP management is tailored to severity and patient age. Coordination among pediatricians, endocrinologists, dentists and geneticists is essential.
Medical Therapies
Dental Care
Orthopedic Care
Early recognition of HPP lets patients and families:
Psychosocial support is also key. While HPP is a lifelong condition, many people lead full, active lives with appropriate treatment and follow-up.
If you or your child experiences early tooth loss without root resorption—especially primary incisors before age 4—consider evaluating for HPP. Other red flags include unexplained bone pain, frequent fractures, or low ALP on routine blood tests.
You might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to help organize your symptoms before speaking with a specialist.
Whole teeth falling out without root resorption is far from routine. In most cases, this pattern signals hypophosphatasia, a metabolic bone disease that benefits greatly from early diagnosis and targeted treatment. If any part of this sounds familiar or concerning, please speak to a doctor or dentist promptly. Early intervention can make a significant difference in outcomes and quality of life.
(References)
* Mornet E. Hypophosphatasia. Best Pract Res Clin Rheumatol. 2008 Mar;22(1):113-27. doi: 10.1016/j.berh.2007.11.003. PMID: 18328985.
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Dahir KM, Nunes ME. Hypophosphatasia. 1993. PMID: 20301329.
* Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016 Apr;12(4):233-46. doi: 10.1038/nrendo.2016.14. 2016 Feb 19. PMID: 26893260.
* Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016 Jun;14(3):95-105. doi: 10.1007/s11914-016-0309-0. PMID: 27084188.
* Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. 2017 Jul 25. PMID: 28888853.
* Tournis S, Yavropoulou MP, Polyzos SA, Doulgeraki A. Hypophosphatasia. J Clin Med. 2021 Dec 1;10(23). doi: 10.3390/jcm10235676. 2021 Dec 1. PMID: 34884378; PMCID: PMC8658462.
* Spodzieja K, Olczak-Kowalczyk D. Premature Loss of Deciduous Teeth as a Symptom of Systemic Disease: A Narrative Literature Review. Int J Environ Res Public Health. 2022 Mar 13;19(6). doi: 10.3390/ijerph19063386. 2022 Mar 13. PMID: 35329073; PMCID: PMC8953685.
* Khan AA, Rush ET, Wakeford C, Staub D, Brandi ML. Key Learnings from Clinical Research and Real-World Evidence on Asfotase Alfa Effectiveness in Hypophosphatasia: 10 Years Post-Approval. Adv Ther. 2025 Sep;42(9):4270-4299. doi: 10.1007/s12325-025-03309-1. 2025 Jul 25. PMID: 40715944; PMCID: PMC12394269.
* Gill AS, Sharma P, Nassar M, Marte E. Hypophosphatasia: A case report. World J Clin Cases. 2025 Jul 26;13(21):103642. doi: 10.12998/wjcc.v13.i21.103642. PMID: 40726933; PMCID: PMC12068182.
* Whyte MP. Hypophosphatasia: who among us is a carrier? J Bone Miner Res. 2026 Mar 2;41(3):195-198. doi: 10.1093/jbmr/zjag003. PMID: 41530828.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.